艾博特·爱比克 (Abbott Epic) mitrale 生物假体的中期结果和血液动力学表现:单中心研究
Takayuki Gyoten1, Yu Miyama2, Yu Kumagai3
1Department of Cardiovascular Surgery, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, Japan. t.gyoten29@gmail.com.
General thoracic and cardiovascular surgery
|October 28, 2025
概括
使用Epic生物假体进行手术中部置换的中期结果显示了令人满意的临床结果. 这项研究强调了稳定的血液动力学和在五年内结构的恶化和重新干预率非常低.
科学领域:
- 心血管外科心血管外科
- 生物假体门的使用方法
- 心脏门的更换 心脏门的更换
背景情况:
- 手术中关置换 (MVR) 是严重的中关疾病的关键手术.
- 生物假体提供了机械的替代品,但它们的长期耐用性是关键考虑因素.
- 像Epic假肢这样的特定生物假肢门的中期性能的现实数据对于临床决策至关重要.
研究的目的:
- 评估使用Epic生物假体进行手术中枢置换 (MVR) 的中期临床经验和结果.
- 评估Epic生物假体在现实环境中的生存率,再干预率和血液动力学性能.
- 报告Epic生物假体植入后发生的重大心脏不良事件和门特异性并发症.
主要方法:
- 在2012年至2023年期间,对122名用Epic生物假体进行了手术关节置换 (MVR) 的患者进行了回顾性分析.
- 对术后结果的评估,包括全因死亡率,不需要米特拉重新干预和主要心脏不良事件.
- 血液动力学性能分析,包括压力梯度,以及对结构的恶化在33个月的中位随访期间的评估.
主要成果:
- 一,三,五年总生存率分别为86.8%,82.0%和76.9%.
- 没有因心力衰竭而重新住院的情况很高,一年后的病例率为96.7%,3年后的病例率为95.5%,5年后的病例率为91.2%.
- 由于门恶化,只有一名患者需要重新干预,血液动力学性能在整个随访期间保持稳定.
结论:
- 使用Epic生物假体进行手术中关节置换 (MVR) 显示出令人满意的中期临床结果.
- 在5年的时间里,Epic生物假体表现出稳定的血液动力学性能,结构膜恶化和重新干预的发病率非常低.
- 这些发现支持Epic生物假体在真实世界的临床实践中用于 mitra 置换的使用.
更多相关视频
相关概念视频
01:25Mitral Regurgitation III: Medical Management
268
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
268
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
213
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
213
01:22Mitral Valve Prolapse II: Assessment and Management
406
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
406